Copyright
©The Author(s) 2017.
World J Gastroenterol. Oct 21, 2017; 23(39): 7160-7167
Published online Oct 21, 2017. doi: 10.3748/wjg.v23.i39.7160
Published online Oct 21, 2017. doi: 10.3748/wjg.v23.i39.7160
Table 1 Baseline characteristics of cholangiocarcinoma patients diagnosed between 2009 and 2013 n (%)
Variable | CCA cases(n = 39421) | Thai population(n = 64076033) | P value |
Gender | |||
Male | 24120 (61.2) | 31529148 (49.2) | < 0.001 |
Age (mean ± SD, yr) | 64.1 ± 11.7 | 34.91 | |
Geographic region | < 0.0001 | ||
Northeast | 24239 (61.5) | 21585883 (33.7) | < 0.001 |
North | 6699 (17.0) | 11783311 (18.4) | < 0.001 |
Central | 5295 (13.4) | 16060141 (25.1) | < 0.001 |
Bangkok | 1114 (2.8) | 5674843 (8.8) | < 0.001 |
South | 1056 (2.7) | 8971855 (14.0) | < 0.001 |
Table 2 Incidence (per 100000 persons) of cholangiocarcinoma in Thailand during the 2009 to 2013 study period
Region | Year | Ptrend value | ||||
2009 | 2010 | 2011 | 2012 | 2013 | ||
All | 15.80 | 15.63 | 16.13 | 16.07 | 16.43 | 0.13 |
Northeast | 28.71 | 28.33 | 28.96 | 29.30 | 28.83 | 0.25 |
North | 19.59 | 18.80 | 19.46 | 18.80 | 20.84 | 0.70 |
Central | 7.23 | 7.42 | 7.98 | 8.40 | 9.20 | 0.06 |
Bangkok | 5.87 | 6.17 | 6.27 | 5.52 | 6.01 | 0.85 |
South | 2.76 | 2.74 | 2.98 | 2.81 | 2.98 | 0.17 |
Table 3 Proportions of individuals with potential predisposing conditions to cholangiocarcinoma development n (%)
Conditions | CCA patients (n = 39421) | Non-CCA patients (n = 18508448) | P value |
Cirrhosis | 1896 (4.81) | 170255 (0.92) | < 0.001 |
Chronic viral hepatitis B infection | 291 (0.74) | 21797 (0.12) | < 0.001 |
Chronic viral hepatitis C infection | 196 (0.50) | 18339 (0.10) | < 0.001 |
Diabetes | 4502 (11.42) | 977973 (5.28)1 | < 0.001 |
Table 4 Proportion of cholangiocarcinoma patients who had underlying diabetes and chronic liver diseases n (%)
Total(n = 39421) | Northeast(n = 24237) | North(n = 6696) | PNorthvsNortheast | Central(n = 5294) | PcentralvsNortheast | Bangkok(n = 1113) | PBangkokvsNortheast | South(n = 1055) | PSouthvsNortheast | Pfor all regions | |
Diabetes | 4502 (11.42) | 2803 (11.56) | 572 (8.54) | < 0.0001 | 689 (13.01) | 0.11 | 389 (18.36) | < 0.0001 | 133 (12.60) | 0.25 | < 0.0001 |
Cirrhosis | 1896 (4.81) | 963 (3.97) | 440 (5.39) | < 0.0001 | 362 (6.84) | < 0.0001 | 83 (7.46) | < 0.0001 | 63 (5.97) | < 0.0001 | < 0.0001 |
Chronic hepatitis B | 291 (0.74) | 106 (0.44) | 91 (1.36) | < 0.0001 | 59 (1.11) | < 0.0001 | 18 (1.62) | 0.05 | 12 (1.52) | 0.002 | < 0.0001 |
Chronic hepatitis C | 196 (0.50) | 92 (0.38) | 57 (0.85) | < 0.0001 | 20 (0.38) | 0.33 | 17 (1.53) | 0.12 | 3 (0.28) | < 0.001 | < 0.0001 |
Table 5 One-year mortality rate in cholangiocarcinoma patients by region during the 2009 to 2013 study period n (%)
Year | Region | Total | ||||
Northeast | North | Central | Bangkok | South | ||
2009 | 3825 (79.6) | 1153 (85.5) | 754 (80.6) | 170 (78.7) | 149 (74.5) | 6051 (80.6) |
2010 | 3928 (82.4) | 1114 (86.1) | 782 (81.0) | 181 (80.4) | 148 (74.0) | 6153 (82.6) |
2011 | 3988 (82.1) | 1097 (83.0) | 830 (80.0) | 176 (78.2) | 172 (78.5) | 6263 (81.8) |
2012 | 4087 (82.5) | 1068 (82.3) | 893 (79.7) | 174 (81.3) | 176 (83.4) | 6398 (82.0) |
2013 | 3973 (81.9) | 1208 (84.2) | 986 (79.9) | 169 (72.5) | 165 (73.3) | 6501 (81.5) |
Ptrend | 0.57 | 0.25 | 0.13 | 0.57 | 0.85 | 0.85 |
- Citation: Chaiteerakij R, Pan-ngum W, Poovorawan K, Soonthornworasiri N, Treeprasertsuk S, Phaosawasdi K. Characteristics and outcomes of cholangiocarcinoma by region in Thailand: A nationwide study. World J Gastroenterol 2017; 23(39): 7160-7167
- URL: https://www.wjgnet.com/1007-9327/full/v23/i39/7160.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i39.7160